A I-designed proteins may help spot cancer
Nanoparticles coated with the molecular sensors could be used in at-home diagnostics.
Researchers at MIT and Microsoft have used artificial intelligence to create molecular sensors that could detect early signs of cancer via a urine test.
The researchers developed an AI model to design short proteins that are targeted by enzymes called proteases, which are overactive in cancer cells. Nanoparticles coated with these proteins, called peptides, can give off a signal if they encounter cancer-linked proteases once introduced into circulation: The proteases will snip off the peptides, which then form reporter molecules that are excreted in urine.
Sangeeta Bhatia, SM ’93, PhD ’97, a senior author of a paper on the work with her former student Ava Amini ’16, a principal researcher at Microsoft Research, led the MIT team that came up with the idea of such particles over a decade ago. But earlier efforts used trial and error to identify peptides that would be cleaved by specific proteases, and the results could be ambiguous. With AI, peptides can be designed to meet specific criteria.
“If we know that a particular protease is really key to a certain cancer, and we can optimize the sensor to be highly sensitive and specific to that protease, then that gives us a great diagnostic signal,” Amini says.
Bhatia’s lab is now working with ARPA-H on an at-home kit that could potentially detect 30 types of early cancer. Peptides designed using the model could also be incorporated into cancer therapeutics.
Keep Reading
Most Popular
A startup claims it broke through a bottleneck that’s holding back LLMs
Subquadratic has now shared more details about its new model. But some are still skeptical.
China has approved the world’s first invasive brain-computer chip—here’s what’s next
The country wants to become a global leader in brain implants. Strong government support is expected to help accelerate that process.
The “steroid olympics” were a circus—and a window into our culture
Dozens of athletes on performance-enhancing drugs competed in the Enhanced Games. Organizers hope it'll sell a lot of peptides and other supplements.
Sperm donors need limits, says a European fertility group
Some donor-conceived people are finding hundreds of siblings. An international cap on donations could help prevent that.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.